March 11 eveningannouncementFeatured:Chinese medicinesay,PfizerThe new crown medicine has not yet entered the national medical insurance and the new crown diagnosis and treatment plan;NorwegianNew coronavirus antigen detection kit obtainedmedical instrumentsregistration certificate;BeiGeneThe core product Baizean was approved to treat patients with MSI-H or dMMR solid tumors;Shengxing sharesChairman Lin Yongxian is suspected ofsecuritiesMarket manipulation was filed by the China Securities Regulatory Commission;Debon shareswelcomeJD.comInter-group acquisition of the owner, or privatization in the future;LianyungangIt is proposed to raise no more than 1.5 billion yuan, and introduceSIPGcast for battleLong-term Lithium Branchto be issuedconvertible bondsThe fundraising shall not exceed 3.25 billion yuan;Oriental ShenghongPromote employee stock ownership plan, holdingshareholderand employees of affiliated companies planning to increase their holdings;Reclaimed water fisheryThe person acting in concert with the actual controller intends to increase its holdings by 1%-2%;Kaiying Networksome directors,executiveIt is proposed to increase the shareholding of not less than 30 million yuan;UF networkProposed 600 million to 1 billion yuanreposhares.
(Article Source:securitiesTimes e company)
Article source: Securities Times · e company
Responsible editor: 83
Original title: Featured Announcement: Lianyungang plans to introduce Shanghai Port Group as a strategic investment; Debon shares will welcome Jingdong Group’s indirect access to the main
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
report
Scan the QR code to follow
Oriental Fortune official website WeChat